Evidence map›Paper›PMID 34103529›Full record

ArticleNature communications2021

Sugar phosphate activation of the stress sensor eIF2B.

Qi Hao, Jin-Mi Heo, Boguslaw P Nocek, Kevin G Hicks, Vincent S Stoll, Clint Remarcik, Sean Hackett, Lauren LeBon, Rinku Jain, Dan Eaton and 3 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Regulation of RNA-binding proteins by small biomolecules.Nature reviews. Molecular cell biology · 2026
    Review
  3. Termination of the integrated stress response.Science (New York, N.Y.) · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Signaling plasticity in the integrated stress response.Frontiers in cell and developmental biology · 2023
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Qi Hao *Calico Life Sciences LLC, South San Francisco, CA, USA.
Jin-Mi Heo *Calico Life Sciences LLC, South San Francisco, CA, USA.
Boguslaw P NocekResearch & Development, AbbVie, North Chicago, IL, USA.
Kevin G HicksDepartment of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT, USA.ORCID 0000-0001-5067-7608
Vincent S StollResearch & Development, AbbVie, North Chicago, IL, USA.
Clint RemarcikCalico Life Sciences LLC, South San Francisco, CA, USA.
Sean HackettCalico Life Sciences LLC, South San Francisco, CA, USA.ORCID 0000-0002-9553-4341
Lauren LeBonCalico Life Sciences LLC, South San Francisco, CA, USA.ORCID 0000-0003-3205-1948
Rinku JainResearch & Development, AbbVie, North Chicago, IL, USA.
Dan EatonCalico Life Sciences LLC, South San Francisco, CA, USA.
Jared RutterDepartment of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT, USA.ORCID 0000-0002-2710-9765
Yao Liang WongCalico Life Sciences LLC, South San Francisco, CA, USA. yao@calicolabs.com.ORCID 0000-0003-0298-8510
Carmela SidrauskiCalico Life Sciences LLC, South San Francisco, CA, USA. carmela@calicolabs.com.ORCID 0000-0002-4850-3112
AbbVie (United States) · USISCO International (United States) · USHoward Hughes Medical Institute · USLoxo Oncology at Lilly (United States) · USUniversity of Utah · US

Funding

Interdisciplinary Training Program in MetabolismT32DK091317 · NIDDK · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI SCOTT A SUMMERS · 2011 to 2026
$4.8M
Howard Hughes Medical InstituteNIDDK NIH HHS T32 DK091317
6 · The paper itself

Abstract

The multi-subunit translation initiation factor eIF2B is a control node for protein synthesis. eIF2B activity is canonically modulated through stress-responsive phosphorylation of its substrate eIF2. The eIF2B regulatory subcomplex is evolutionarily related to sugar-metabolizing enzymes, but the biological relevance of this relationship was unknown. To identify natural ligands that might regulate eIF2B, we conduct unbiased binding- and activity-based screens followed by structural studies. We find that sugar phosphates occupy the ancestral catalytic site in the eIF2Bα subunit, promote eIF2B holoenzyme formation and enhance enzymatic activity towards eIF2. A mutant in the eIF2Bα ligand pocket that causes Vanishing White Matter disease fails to engage and is not stimulated by sugar phosphates. These data underscore the importance of allosteric metabolite modulation for proper eIF2B function. We propose that eIF2B evolved to couple nutrient status via sugar phosphate sensing with the rate of protein synthesis, one of the most energetically costly cellular processes.

Indexed as

Stress, PhysiologicalAllosteric RegulationBinding SitesConserved SequenceCryoelectron MicroscopyEukaryotic Initiation Factor-2BEvolution, MolecularGuanosine DiphosphateHEK293 CellsHumansLeukoencephalopathiesLigandsMetabolomeModels, MolecularMutationProtein SubunitsEukaryotic Initiation Factor-2BGuanosine DiphosphateLigandsProtein SubunitsSugar Phosphates

Identifiers

PMID34103529
PMCPMC8187479
OpenAlexW3167154174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.